A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)

Study Identifier
MAF/AGN/OPH/RET/011
CT.gov Identifier
NCT01571557
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Macular Edema
    • Study Drug
  • dexamethasone 700 ug intravitreal implant
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Diagnosis of macular edema following retinal vein occlusion * Prescribed OZURDEX®
    Exclusion Criteria:
    * Previous treatment with OZURDEX®

    Protocol Summary

    This study will evaluate the relationship between time since onset of macular oedema symptoms and the achievement of vision gain in patients prescribed OZURDEX®. All care and diagnostic procedures provided are at the discretion of the participating physicians according to their clinical judgment and local standard of medical care.

    Study Locations

    Location
    Status
    Location
    Berlin, Germany
    Status
    Not applicable